Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?

BACKGROUND: The aim of this study was to perform a literature-based meta-analysis to assess the efficacy of the novel immune checkpoint inhibitors (ICIs) in first-line metastatic renal cell carcinoma (RCC), focusing on the predictive role of PD-L1 expression. METHODS: The primary outcome was overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Roviello, Giandomenico, Corona, Silvia Paola, Nesi, Gabriella, Mini, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683319/
https://www.ncbi.nlm.nih.gov/pubmed/31428205
http://dx.doi.org/10.1177/1758835919861905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683319/
https://www.ncbi.nlm.nih.gov/pubmed/31428205
http://dx.doi.org/10.1177/1758835919861905

Ejemplares similares